(Q39620511)

13 September 2017

title

Checkpoint kinase inhibitor synergizes with DNA-damaging agents in G1 checkpoint-defective neuroblastoma (English)

1 reference

13 September 2017

6

Nai-Kong V Cheung

1 reference

13 September 2017

2

Irene Y Cheung

1 reference

13 September 2017

Hong Xu

1

1 reference

13 September 2017

Xiao X Wei

series ordinal

3

1 reference

13 September 2017

Hoa Tran

series ordinal

4

1 reference

13 September 2017

Xiaoni Gao

series ordinal

5

1 reference

13 September 2017

language of work or name

English

0 references

publication date

8 March 2011

1 reference

International Journal of Cancer

13 September 2017

published in

1 reference

13 September 2017

volume

129

1 reference

13 September 2017

issue

8

1 reference

13 September 2017

page(s)

1953-1962

1 reference

The DNA damage response: ten years after

13 September 2017

cites work

1 reference

Cell cycle kinases as therapeutic targets for cancer

21 January 2018

1 reference

New insights into checkpoint kinase 1 in the DNA damage response signaling network

21 January 2018

1 reference

AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies

21 January 2018

1 reference

Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapse

21 January 2018

1 reference

21 January 2018

Surfing the p53 network

1 reference

Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients

21 January 2018

1 reference

MDM2SNP309 genotype influences survival of metastatic but not of localized neuroblastoma

21 January 2018

1 reference

Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14(ARF)-MDM2-p53 axis.

21 January 2018

1 reference

High Frequency of p53/MDM2/p14ARF Pathway Abnormalities in Relapsed Neuroblastoma

21 January 2018

1 reference

Expression of C-terminal deleted p53 isoforms in neuroblastoma

21 January 2018

1 reference

Cytogenetic and molecular characterization of a newly established neuroblastoma cell line LS.

21 January 2018

1 reference

Chromosomal aberrations in human neuroblastomas

21 January 2018

1 reference

The p53 pathway and its inactivation in neuroblastoma.

21 January 2018

1 reference

Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation

21 January 2018

1 reference

Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies

21 January 2018

1 reference

Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study

21 January 2018

1 reference

Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma

21 January 2018

1 reference

Chk1 requirement for high global rates of replication fork progression during normal vertebrate S phase

21 January 2018

1 reference

Mechanisms of apoptosis induction by nucleoside analogs.

21 January 2018

1 reference

Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent protein kinase

21 January 2018

1 reference

Sensitivity to gemcitabine and its metabolizing enzymes in neuroblastoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.25842

1 reference

13 September 2017

1 reference